The significance of endothelium-derived hyperpolarizing factor in the human circulation

Current Vascular Pharmacology

Volumn 5, Issue 1, 2007, Pages 85-92

  Yang, Qin ^a   Yim, Anthony P C ^b   He, Guo Wei ^a,b,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

Atherosclerosis; Diabetes; Endothelium derived hyperpolarizing factor (EDHF); Heart failure; Human vasculature; Hypertension; Nitric oxide; Pregnancy

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; BRADYKININ; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYTOCHROME P450; DOBESILATE CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ESTRADIOL; INWARDLY RECTIFYING POTASSIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; POTASSIUM CHANNEL; TETRYLAMMONIUM CHLORIDE; BIOLOGICAL FACTOR; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; UNCLASSIFIED DRUG;

AGING; ARTERY TRANSPLANTATION; ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL TONE; CIRCULATION; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GLAUCOMA; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HORMONE ACTION; HUMAN; HYPERTENSION; INSULIN DEFICIENCY; INSULIN RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREGNANCY; REPERFUSION INJURY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; UTERUS RELAXATION; VASCULAR PATENCY; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASE; PHYSIOLOGY;

ANIMALS; BIOLOGICAL FACTORS; BLOOD CIRCULATION; BLOOD VESSELS; CARDIOVASCULAR DISEASES; HUMANS; VASODILATION;

EID: 34247096146     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016107779317206     Document Type: Review

References (104)

1. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988; 93: 515-24.
2. Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988; 98: 1165-74.
3. Ge ZD, Zhang XH, Fung PC, He GW. Endothelium-dependent hyperpolarization and relaxation resistance to NG-nitro-L-arginine and indomethacin in coronary circulation. Cardiovasc Res 2000; 46: 547-56.
4. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-80.
5. Mombouli JV, Bissiriou I, Agboton VD, Vanhoutte PM. Bioassay of endothelium-derived hyperpolarizing factor. Biochem Biophys Res Commun 1996; 221: 484-8.
6. Randall MD, Kendall DA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 1997; 335: 205-9.
7. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269-72.
8. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521-30.
9. Vanhoutte PM. Vascular biology. Old-timer makes a come-back. Nature 1998; 396: 213, 215-6.
10. Yamamoto Y, Imaeda K, Suzuki H. Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles. J Physiol 1999; 514: 505-13.
11. Kauser K, Rubanyi GM. Bradykinin-induced, Nomega-nitro-L-arginine-insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances. J Cardiovasc Phamacol 1992; 20: S101-4.
12. Taylor HJ, Chaytor AT, Edwards DH, Griffith TM. Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries. Biochem Biophys Res Commun 2001; 283: 583-9.
13. Chaytor AT, Taylor HJ, Griffith TM. Gap junction-dependent and - independent EDHF-type relaxations may involve smooth muscle cAMP accumulation. Am J Physiol 2002; 282: H1548-55.
14. Kemp BK, Cocks TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol 1997; 120: 757-62.
15. He GW. Hyperkalemia exposure impairs EDHF-mediated endothelial function in the human coronary artery. Ann Thorac Surg 1997; 63: 84-7.
16. + channels. Circ Res 1998; 83: 501-7.
17. + channels. Circulation 1999; 99: 3132-8.
18. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003; 92: E31-40.
19. Kessler P, Lischke V, Hecker M. Etomidate and thiopental inhibit the release of endothelium-derived hyperpolarizing factor in the human renal artery. Anesthesiology 1996; 84: 1485-8.
20. Bussemaker E, Popp R, Binder J, Busse R, Fleming I. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human unterlobar artery. Kidney Int 2003; 63: 1749-55.
21. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997; 100: 2793-9.
22. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 2002; 290: 909-13.
23. Morikawa K, Fujiki T, Matoba T, Kubota H, Hatanaka M, Takahashi S, et al. Important role of superoxide dismutase in EDHF-mediated responses of human mesenteric arteries. J Cardiovasc Pharmacol 2004; 44: 552-6.
24. Tottrup A, Kraglund K. Endothelium-dependent responses in small human mesenteric arteries. Physiol Res 2004; 53: 255-63.
25. Hamilton CA, McPhaden AR, Berg G, Pathi V, Dominiczak AF. Is hydrogen peroxide an EDHF in human radial arteries? Am J Physiol 2001; 280: H2451-5.
26. He GW. Nitric oxide and endothelium-derived hyperpolarizing factor in human arteries and veins, J Card Surg 2002; 17: 317-23.
27. He GW, Liu ZG. Comparison of nitric oxide release and endothelium-derived hyperpolarizung factor-mediated hyperpolarization between human radial and internal mammary arteries. Circulation 2001; 104: I344-9.
28. Liu ZG, Ge ZD, He GW. Difference in endothelium-derived hyperpolarizing factor-mediated hyperpolarization and nitric oxide release between human internal mammary artery and saphenous vein. Circulation 2000; 102: III296-301.
29. Yang JA, He GW. Surgical preparation abolishes endothelium-derived hyperpolarizing factor-mediated hyperpolarization in the human saphenous vein. Ann Thorac Surg 1997; 63: 429-33.
30. Wihlborg AK, Malmsjo M, Eyjolfsson A, Gustafsson R, Jacobson K, Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br J Pharmacol 2003; 138: 1451-8.
31. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, et al. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 2003; 107: 769-76.
32. + channels mediate relaxation of forearm veins in chronic renal failure. J Hypertens 2003; 21: 1927-34.
33. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol 2001; 280: H2470-7
34. Honing ML, Smits P, Morrison PJ, Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension 2000; 35: 1314-8.
35. Katz SD, Krum H. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: Indirect evidence for the role of endothelium-derived hyperpolarizing factor. Am J Cardiol 2001; 87: 1089-92
36. Luksha L, Nisell H, Kublickiene K. The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am J Physiol 2004; 286: R1102-9.
37. McIntyre CA, Buckley CH, Jones GC, Sandeep TC, Andrews RC, Elliott AI, et al. Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries. Br J Pharmacol 2001; 133: 902-8.
38. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Endothelium-derived hyperpolarizing factor: Identification and mechanisms of action in human subcutaneous resistance arteries. Circulation 2001; 103: 1702-8.
39. + currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels. J Physiol 2001; 531: 359-73.
40. Cleary C, Buckley CH, Henry E, McLoughlin P, O'Brien C, Hadoke PW. Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: Implications for vascular function in the eye. Br J Ophthalmol 2005; 89: 223-8.
41. Ohlmann P, Martinez MC, Schneider F, Stoclet JC, Andriantsitohaina R. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. Br J Pharmacol 1997; 121: 657-64.
42. Wallerstedt SM, Bodelsson M. Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: Relative contribution of prostanoids, nitric oxide and hyperpolarization. Br J Pharmacol 1997; 120: 25-30.
43. Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A, et al. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003a; 312: 1202-8.
44. Angulo J, Cuevas P, Fernandez A, Gabancho S, Videla S, Sáenz de Tejada I. Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries. Br J Pharmacol 2003b; 139: 854-62.
45. Garcia-Pascual A, Labadia A, Triguero D, Costa G. Local regulation of oviductal blood flow. Gen Pharmacol 1996; 27: 1303-10.
46. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br J Pharmacol 2002a; 136: 1085-8
47. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci 2002b; 103: 67-73.
48. Torondel B, Vila JM, Segarra O, Lluch P, Medina P, Martinez-Leon J, et al. Endothelium-dependent responses in human isolated thyroid arteries from donors. J Endocrinol 2004; 181: 379-84.
49. Zygmunt PM, Edwards G, Weston AH, Larsson B, Hogestatt ED. Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. Br J Pharmacol 1997; 121: 141-9.
50. Petersson J, Zygmunt PM, Hogestatt ED. Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br J Pharmacol 1997; 120: 1344-50.
51. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am J Physiol 1990; 259: H668-73.
52. Plane F, Garland CJ. Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery. Br J Pharmacol 1993; 110: 651-6.
53. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996; 94: 3341-7.
54. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol 2000; 279: H459-65.
55. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 2000; 36: 1233-8.
56. Gilligan DM, Quyyumi AA, Cannon RO 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994a; 89: 2545-51.
57. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994b; 90: 786-91.
58. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998; 32: 730-4.
59. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Short term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J cardiovasc pharmacol 1997; 30: 481-8.
60. Rahimian R, Chan L, Goel A, Poburko D, van Breemen C. Estrogen modulation of endothelium-derived relaxing factors by human endothelial cells. Biochem Biophys Res Commun 2004; 322: 373-9.
61. Koga T, Takata Y, Kobayashi K, Takishita S, Yamashita Y, Fujishima M. Ageing suppresses endothelium-dependent relaxation and generates contraction mediated by the muscarinic receptors m vascular smooth muscle of normotensive Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens Suppl 1988; 6: S243-5.
62. Hongo K, Nakagomi T, Kassell NF, Sasaki T, Lehman M, Vollmer DG, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke 1988; 19: 892-7.
63. Fujii K, Ohmori S, Tominaga M, Abe I, Takata Y, Ohya Y, et al. Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol 1993; 265: H509-16.
64. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77-81
65. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Agmg and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981-7.
66. Al-shaer MH, Choueiri NE, Correia ML, Sinkey CA, Barenz TA, Haynes WG. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans, Int J Cardiol 2006; 109: 201-6
67. Pascoal IF, Umans JG. Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension 1996; 28: 183-7
68. McCarthy AL, Taylor P, Graves J, Raju SK, Poston L. Endothelium-derived relaxation of human resistance arteries in pregnancy. Am J Obstet Gynecol 1994; 171: 1309-15.
69. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal-resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175: 1668-74.
70. McCarthy AL, Woofson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168: 1323-30.
71. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510-6.
72. Triggle CR, Ding H, Anderson TJ, Pannireselvam M. The endothelium in health and disease: A discussion of the contribution of nonnitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol Cell Biochem 2004; 263: 21-7.
73. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina study. J Urol 2001; 166: 569-74.
74. Fang X, Kaduce TL, Weintraub NL, Harmon S, Teesch LM, Morisseau C, et al. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells: Implication for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem 2001; 276: 14867-74.
75. Sandberg M, Hassett C, Adman ET, Meijer J, Omiecinski CJ. Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 2000; 275: 28873-81
76. Ohtoshi K, Kaneto H, Node K, Nakamura Y, Shiraiwa T, Matsuhisa M, et al. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem Biophys Res Commun 2005; 331: 347-50
77. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-40.
78. Thybo NK, Mulvany MJ, Jastrup B, Nielsen H, Aalkjaer C. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens 1996; 14: 993-8.
79. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-33.
80. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: Mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci 1995; 88: 611-22.
81. Luscher TF. Heterogeneity of endothelial dysfunction in hypertension. Eur Heart J 1992; 13 Suppl D: 50-5.
82. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-303.
83. Paniagua OA, Bryant MB, Panza JA. Transient hypertnesion directly impairs endothelium-dependent vasodilation of the human microvasculature. Hypertension 2000; 36: 941-4.
84. Paniagua OA, Bryant MB, Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: Diminished activity in hypertensive and hypercholesterolemic patients. Circulation 2001; 103: 1752-8.
85. Yang R, Ogasawara AK, Zioncheck TF, Ren Z, He GW, DeGuzman GG, et al. Exaggerated Hypotensive Effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats. Hypertension 2002; 39: 815-20
86. Mantelli L, Amerini S, Ledda F. Role of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol 1995; 25: 595-602.
87. Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, et al. Mechanisms for altered endothelium-dependent relaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol 1993; 264: H1535-41.
88. Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol 1999; 126: 709-16.
89. Sofola OA, Knill A, Hainsworth R, Drinkhill M. Changes in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 2002; 543: 255-60.
90. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170-4
91. Shimokawa H, Vanhoutte PM. Endothelium and vascular injury in hypertension and atherosclerosis. In: Zanchetti A, Marcia G (eds). Handbook of Hyper tension. New York: Elsevier Science 1997; 1007-65.
92. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-92.
93. Liu SY, Lu X, Choy S, Dembinski TC, Hatch GM, Mymin D, et al. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation. Cardiovasc Res 1994; 28: 1476-81.
94. Froese DE, McMaster J, Man RY, Choy PC, Kroeger BA. Inhibition of endothelium-dependent vascular relaxation by lysophosphatidylcholine: impact of lysophosphatidylcholine on mechanisms involving endothelium-derived nitric oxide and endothelium derived hyperpolarizing factor. Mol Cell Biochem 1999; 197: 1-6.
95. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilatation is attenuated in patients with heart failure. Circulation 1991; 84: 1589-96.
96. Dong YY, Wu M, Yim AP, He GW. Hypoxia-reoxygenation, St. Thomas cardioplegic solution, and nicorandil on endothelium-derived hyperpolarizing factor in coronary microarteries. Ann Thorac Surg 2005; 80: 1803-11.
97. Dong YY, Wu M, Yim AP, He GW. Effect of hypoxia-reoxygenation on endothelial function in porcine cardiac microveins. Ann Thorac Surg 2006; 81: 1708-14.
98. Ren Z, Yang Q, Floten HS, Furnary AP, Yim AP, He GW. ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery. Ann Thorac Surg 2001; 71: 642-7.
99. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, Gutterman DD. Peroxynitrite Inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles Circ Res 2002; 91: 1070-6.
100. Feletou M, Vanhoutte PM. EDHF: New therapeutic targets? Pharmacol Res 2004; 49: 565-80.
101. Tran D, Lowy A, Howes JB, Howes LG. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men. Diabetes Obes Metab 2005; 7: 273-81.
102. Kansui Y, Fujii K, Goto K, Abe I, Iida M. Effects of fluvastatin on endothelium-derived hyperpolarizing factor- and nitric oxide-mediated relaxations in arteries of hypertensive rats. Clin Exp Pharmacol Physiol 2004; 31: 354-9.
103. Zou W, Yang Q, Yim AP, He GW. Epoxyeicosatrienoic acids (EET(11,12)) may partially restore endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries. Ann Thorac Surg 2001; 72: 1970-6.
104. Yang Q, Zhang RZ, Yim AP, He GW. Effect of 11,12-epoxyeicosatrienoic acid as an additive to St. Thomas' cardioplegia and University of Wisconsin solutions on endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries: Influence of temperature and time. Ann Thorac Surg 2003; 76: 1623-30.